Home Digital Therapeutics Hangzhou City Summit Registration Opens: Blue Ocean Emerges, How to Seize the Opportunity?

Digital Therapeutics Hangzhou City Summit Registration Opens: Blue Ocean Emerges, How to Seize the Opportunity?

Jun 18, 2021 17:17 CST Updated 17:17

In China, although the development of digital therapeutics is still in its early stages, it has attracted significant attention. In the capital market, digital therapeutics companies are also highly favored, with renowned institutions entering the field, later-stage financing rounds becoming common, and single-round funding exceeding RMB 100 million becoming the norm. Recently, Bositen Technology, which provides digital screening and training interventions for dementia, completed an A-round financing of RMB 100 million. Wangli Technology, which focuses on psychiatric digital therapeutics, has also secured tens of millions of yuan in funding.WeimaiZhilan HealthMiao Health...and other companies have disclosed their moves in this field.


The Blue Ocean of Digital Therapeutics Has Emerged: How to Seize the First-Mover Advantage? As academics have stated, “We have already devoted considerable time to contemplating and theorizing about digital health and digital therapeutics; now is the time for action.”


ChinaThe First Digital Therapeutics Organization——The Digital Therapeutics Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Translation and Development (hereinafter referred to as the “Professional Committee (Preparatory)”)Established and currently joined by enterprises/institutionsOver 60Home, all are stakeholders in the digital therapeutics value chain, including insurance payers, pharmaceutical and medical device companies, smart device manufacturers, digital therapeutics innovators, investment institutions, and more. The "Digital Therapeutics Industry Tour in China" is a key project in the annual plan of the Preparatory Committee for the Specialized Committee.June 25AtHangzhouConveneDigital Therapeutics City Summit, with planned invitations to clinical research scholars and investment firms,Digital Therapeutics Innovatoretc., focusing on key issues such as clinical applications, data, regulatory approval, use cases, and business models of digital therapeutics, to promote collaborative cooperation among stakeholders in the value chain of digital therapeutics.


This Urban Summit is hosted byDigital Therapeutics and Systems Engineering Professional Committee (Preparatory), China Association for Promotion of Rehabilitation Technology Translation and DevelopmentHosted by;VCBeat, Yuan Yi Capital, Takeda (China), Viatris, Weimai, Fosun Pharma, Sanofi (China),Zhilan HealthCo-hosted by;Tasly, Senmei Medical, Huanuo Zhisheng, Miao Health, Shukang, Yuanxin Technology, Rendong Medicine, Tigermed Jietong, Good Doctor Hui, Boston TechGu YitangCo-organizer;Yongliu Technology, Yunkai Yamei, ALSOLIFE, BlueRun VenturesSupport.

Digital Therapeutics Hangzhou City Summit

Exploring Industry Pain Points Together Quality Content SharingPainCo-exploration, Sharing High-Quality Content

Novel topics, cutting-edge content.Focusing on hot topics in digital therapeutics such as clinical applications, data, regulatory approval, use cases, and business models, we share insights on industry pain points including the commercialization of digital therapeutic products and pathways to value realization.

A Comprehensive Exploration of Cutting-Edge Practices in the Digital Therapeutics Industry

Prospective invitees include digital therapeutics innovators, clinical research scholars, investment firms, and other stakeholders, including enterprises such as Xiaobeike Software, which has received the first-ever medical device registration certificate in this category.Zhilan Health、The first batch of companies certified by the Digital Therapeutics Alliance (DTA)Weimai...and sharing of real-world clinical data from renowned experts....

Understanding the Industry Landscape, Building Precise Professional Networks

Create a platform for engaging with decision-makers at innovative digital therapeutics companies to facilitate project collaboration, optimize strategic layout, and unlock new business opportunities.


The City Summit adopts a free registration and review system; upon approval, participants may attend the event.

Proposed Agenda:

Time

Form

Proposed Agenda

Proposed Guests


Host: Bi Yuanfeng | Co-founder and COO of VCBeat

14:00-14:05

Opening Remarks

Leader's Address

Yang Han | Deputy Secretary-General and Director of Strategic Development, China Association for the Promotion of Rehabilitation Technology Translation and Development

14:05-14:35

Video Call

"Clinical Practice of 'Digital Prescriptions' in the Diagnosis and Treatment of Chronic Diseases (Proposed)"

Hou Jinlin | Director and Professor, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University

14:35-15:05

Keynote Speech

An Analysis of the Development of Digital Therapeutics Companies in China and Abroad

Yang Ruirong | Partner, Yuanyi Capital

15:05-15:35

Keynote Address

Internet Plus Full-Course Disease Management and Digital Therapeutics

Ying Li | Vice President of Weimai, Medical CenterGeneral Manager

15:35-16:05

Keynote Address

Sharing Experience in the Approval of Digital Therapeutics

Wang Haiwei | Chief Operating Officer, Hangzhou Zhilan Health Co., Ltd.

16:05-16:35

Keynote Address

Exploration of Practical Applications of VR Technology in Digital Therapeutics

Cao Qun | Founder and Chairman of Xinjing Technology

16:35-17:30

Roundtable Discussion

Exploring the Value Realization Pathway of Digital Therapeutics

Host: Song Yiran | Investment Director, Yuanyi Capital

Wan Ma | General Manager, Weimai AI Digital Therapeutics Center; Ph.D.

Wang Haiwei | Chief Operating Officer, Hangzhou Zhilan Health Co., Ltd.

Gao Yunlong | Founder and CEO of Huizhong Respiratory

Liu Wenzhe | Founder and CEO of U-Brain

Peng Yifei | General Manager, Tigermed Jietong


Event Date: June 25

Proposed Invitees:
Pharmaceutical company representatives, digital therapeutics companies, medical device companies, in vitro diagnostics (IVD) companies, industry organizations, healthcare service providers, Internet/TMT companies, domestic and international investment and financing institutions, information service providers, scientific research institutions, etc.
Registration Method

Venue: Hangzhou (specific address to be notified upon approval of registration)

Registration Validity Period: June 15–June 24

Registration Link:http://hdxu.cn/WLNw2

9602330969700_wechat (3).png

(Limited spots available; register early)


About the Organizer

By the National First-Class AssociationChina Association for the Promotion of Rehabilitation Technology Translation and DevelopmentVCBeatYuan Yi CapitalThe First Formal Organization for Digital Therapeutics in China, Jointly Initiated by—Digital Therapeutics and Systems Engineering Professional Committee (Preparatory) of the China Association for Promotion of Rehabilitation Technology Translation and Development (hereinafter referred to as the “Professional Committee (Prep.)”),Voluntarily formed by clinical and research experts in the field of digital therapeutics in China, industry elites, professionals from technology management and technical testing sectors, clinical institutions, research institutes, and related enterprises, it serves as a vital force in the theoretical research and practical development of digital therapeutics systems engineering., the Preparatory Committee aims to:


Promote Industry Consensus: Based on Chinese practices, establish definitions, standards, and specifications for digital therapeutics that align with specific markets, thereby fostering industry consensus;

Promoting Practice in China: On the basis of adhering to relevant principles, explore pathways, identify cases, and create benchmarks to actively advance the practice of digital therapeutics in China;

Creating Value Through Collaboration: Guided by shared values and principles, we actively facilitate in-depth discussions and foster collaborative synergy among diverse stakeholders in the digital therapeutics ecosystem.

Establish a dialogue mechanism: Establish a dialogue mechanism with government regulatory authorities to facilitate full exchange on the progress and challenges in the field of digital therapeutics, and to convey the latest policy directions.


This year is expected toTwo Research Projects2 Dialogue Regulatory Agency ProjectsSix In-Depth Industry Exchange Sessions on Different Themes, 1 annual conference project + N appearances. The annual work plan is as follows:


No.

Project Name

Form

Estimated Completion Time

1

《China Digital Therapeutics White Paper 2021》

Report

Mid-May 2021

2

Special Topic Exchange on Clinical Practice of Digital Therapeutics—Functional Rehabilitation

City Mini Forum, Chongqing

Late May 2021, half a day

3

Special Topic Exchange on Clinical Practice of Digital Therapeutics—Brain Science

City Mini Forum, Hangzhou

June 2021, half a day

4

Special Topic Exchange on Clinical Practice of Digital Therapeutics—Chronic Disease Management

City Mini Forum, Nanjing (Shanghai)

July 2021, half a day

5

A Comparative Study of Digital Therapeutics Policies in China and the United States

Closed-door meeting, approximately 20 attendees, Beijing (or Shanghai)

July 2021, half a day

6

Special Discussion on Reimbursement for Digital Therapeutics

City Mini Forum, Shanghai

August 2021, Half a Day

7

Special Topic Exchange on Digital Therapeutics and Devices

City Mini Forum, Shenzhen

August 2021, Half a Day

8

Seminar on Policy Approval and Industry Practices for Digital Therapeutics

Closed-door meeting, approximately 20 attendees, Chengdu (or Suzhou)

Mid-September 2021, half a day

9

Special Topic Exchange on the Synergy Between Digital Therapeutics and Pharmaceutical Companies

City Mini Forum, Shanghai

Mid-October 2021, half a day

10

"China Digital Therapeutics Industry Development Report 2021"

Report

November–December 2021

11

2021 Digital Therapeutics Annual Conference

Large-scale forum, held independently or concurrently with related events, in Shanghai (or Suzhou)

December 2021, 1 day

12

Co-organize and jointly organize digital therapeutics-related activities

Co-branded Participation

Year-round




Appendix: Digital Therapeutics Activities Conducted

image.png

(April 15, Suzhou: Preparatory Meeting for the Digital Therapeutics Systems Engineering Professional Committee of the China Association for Promotion of Rehabilitation Technology Translation and Development)

image.png

(April 16, Suzhou: The Digital Therapeutics Innovation Forum of the Future Healthcare Top 100 Conference was held)

image.png

(May 28, Chongqing: Study Tour to Senmei Medical, a Benchmark Enterprise in Digital Therapeutics, Held)

image.png

(May 28, Chongqing: The China Digital Therapeutics Industry Tour – Chongqing City Summit Held)


Membership Inquiry: Preparatory Office of the Special Committee

Contact: Fang Qiuxue

Tel: 15208495425

image.png

WeChat: Same as above (please add the note “Special Committee Inquiry” when adding)